Metformin 500 mg Pioglitazone 15 mg Teneligliptin 20 mg Tablet – Manufacturer, Supplier & PCD Franchise



Metformin 500 mg Pioglitazone 15 mg Teneligliptin 20 mg Tablet — available for PCD franchise from Trumac Healthcare

Metformin 500 mg Pioglitazone 15 mg Teneligliptin 20 mg Tablet

Metformin 500 mg Pioglitazone 15 mg Teneligliptin 20 mg — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing

Composition: Metformin 500 mg Pioglitazone 15 mg Teneligliptin 20 mg
Form: Tablet
Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitor — Antidiabetic
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ Available Now

Pricing, brochure & monopoly territory within 24 hrs.

Metformin 500 mg Pioglitazone 15 mg Teneligliptin 20 mg Tablet is available from Trumac Healthcare, a PCD pharma franchise company and supplier in India whose products are made at WHO-GMP certified partner units. This tablet formulation is offered on monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing basis across all Indian states. We already supply Metformin, Pioglitazone, Teneligliptin across our existing range, so supply is established and lead times are short.

Therapeutic Indications
  • Conditions for which a dpp-4 inhibitor is clinically indicated
  • Prescribed as monotherapy or in combination per treating physician
  • Use strictly on the advice of a registered medical practitioner
Mechanism of Action

The dpp-4 inhibitor component inhibits DPP-4, prolonging the action of endogenous incretin hormones and enhancing glucose-dependent insulin secretion. Where the formulation is a fixed-dose combination, the components act complementarily on the target condition. Refer to the approved prescribing information for full pharmacology.

Dosage & Administration
  • Dosage of Metformin 500 mg Pioglitazone 15 mg Teneligliptin 20 mg Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
  • Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
  • Do not exceed the prescribed dose, and complete the full course as advised.
  • Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
  • To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
  • Class-related adverse effects associated with dpp-4 inhibitor therapy
  • Gastrointestinal intolerance in some patients
  • Hypersensitivity reactions (uncommon)
  • Refer to prescribing information for the complete adverse-event profile
Contraindications
  • Known hypersensitivity to any component of the formulation
  • Contraindications applicable to the dpp-4 inhibitor class
  • Use with caution in renal or hepatic impairment
  • Pregnancy and lactation — only if clearly indicated, under medical supervision
Storage

Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.

Offered by Trumac Healthcare, a PCD pharma franchise company, available on a monopoly basis – see the cardiac diabetic pharma franchise product list (PDF). See our full tablet range for PCD franchise. Comparing companies? See the top cardiac-diabetic PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.


Schedule G: Metformin is listed in Schedule G of the Drugs Rules, 1945, so the pack carries the red-box caution “SCHEDULE G PRESCRIPTION DRUG – CAUTION: It is dangerous to take this preparation except under medical supervision”. Combinations that also contain a Schedule H molecule carry the Rx label too. See the Schedule G drugs list.

See the full antidiabetic tablets range – manufacturer, supplier and PCD franchise: SGLT2 and DPP-4 inhibitors, glimepiride, gliclazide, metformin, voglibose and their combinations.

PCD Pharma Franchise & Third Party Manufacturing — Metformin + Pioglitazone + Teneligliptin Tablet

  • ✓ Made at WHO-GMP certified partner units — every batch QC released
  • ✓ Monopoly PCD franchise rights at district or state level
  • ✓ Third party / contract manufacturing under your own brand
  • ✓ Wholesale and distributor supply against drug licence + GST
  • ✓ Attractive net rates with healthy PTR / PTS margins
  • ✓ Dispatch within 48 hours of payment realisation

Composition: Metformin 500 mg Pioglitazone 15 mg Teneligliptin 20 mg. Trumac Healthcare supplies this dpp-4 inhibitor with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.

PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Metformin + Pioglitazone + Teneligliptin Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.

Frequently Asked Questions

Who manufactures Metformin + Pioglitazone + Teneligliptin Tablet in India?

Trumac Healthcare is a supplier of Metformin + Pioglitazone + Teneligliptin Tablet in India; products are made at WHO-GMP certified partner units. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.

Is Metformin + Pioglitazone + Teneligliptin Tablet available for PCD pharma franchise on monopoly basis?

Yes. Metformin 500 mg Pioglitazone 15 mg Teneligliptin 20 mg Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.

Do you offer Metformin + Pioglitazone + Teneligliptin for third party or contract manufacturing?

Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Metformin + Pioglitazone + Teneligliptin Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.

Can Metformin + Pioglitazone + Teneligliptin Tablet be supplied on wholesale or distributor basis?

Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.

What is the therapeutic class of Metformin + Pioglitazone + Teneligliptin?

Metformin + Pioglitazone + Teneligliptin is classified as a DPP-4 Inhibitor — Dipeptidyl Peptidase-4 (DPP-4) Inhibitor — Antidiabetic.

What documentation is provided with each supply?

Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.

How quickly can an order be dispatched?

Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.

Is a prescription required for Metformin + Pioglitazone + Teneligliptin Tablet?

Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.

Ready to start your PCD franchise for Metformin 500 mg Pioglitazone 15 mg Teneligliptin 20 mg Tablet?

Get Pricing & Franchise Terms →